Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (171-180 of 528) with videos related to

Pageof 53
Sort By:
BMC Research Notes|April 4, 2013
Germ-line DICER1 mutations do not make a major contribution to the etiology of familial testicular germ cell tumoursNelly Sabbaghian, Amin Bahubeshi, Andrew Y Shuen, et al.
Plos One|June 11, 2016
Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in MiceKavindra Nath, David S Nelson, Mary E Putt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancersH A Shih, K L Nathanson, S Seal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1977
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovaryW K Tak, M E Costanza, D J Marchant, et al.
JAMA Dermatology|August 1, 2019
Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic DermatitisDavid J Margolis, Nandita Mitra, Bradley Wubbenhorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Structural and functional division into two domains of the large (100- to 115-kDa) chains of the clathrin-associated protein complex AP-2T Kirchhausen, K L Nathanson, W Matsui, et al.
Nature Reviews. Clinical Oncology|June 15, 2016
Counselling framework for moderate-penetrance cancer-susceptibility mutationsNadine Tung, Susan M Domchek, Zsofia Stadler, et al.
Cancer Discovery|November 6, 2013
Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activityLijoy K Mathew, Samuel S Lee, Nicolas Skuli, et al.
Archives of Neurology|April 13, 1999
Successful use of alternate waste nitrogen agents and hemodialysis in a patient with hyperammonemic coma after heart-lung transplantationG T Berry, N D Bridges, K L Nathanson, et al.
Cancer Research|November 19, 2011
Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targetsVijay R Dondeti, Bradley Wubbenhorst, Priti Lal, et al.
Pageof 53

Showing results (171-180 of 528) with videos related to

Sort By:
Pageof 53
BMC Research Notes|April 4, 2013
Germ-line DICER1 mutations do not make a major contribution to the etiology of familial testicular germ cell tumoursNelly Sabbaghian, Amin Bahubeshi, Andrew Y Shuen, et al.
Plos One|June 11, 2016
Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in MiceKavindra Nath, David S Nelson, Mary E Putt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancersH A Shih, K L Nathanson, S Seal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1977
Surgery, chemotherapy and supervoltage radiotherapy for carcinoma of the ovaryW K Tak, M E Costanza, D J Marchant, et al.
JAMA Dermatology|August 1, 2019
Association of Filaggrin Loss-of-Function Variants With Race in Children With Atopic DermatitisDavid J Margolis, Nandita Mitra, Bradley Wubbenhorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Structural and functional division into two domains of the large (100- to 115-kDa) chains of the clathrin-associated protein complex AP-2T Kirchhausen, K L Nathanson, W Matsui, et al.
Nature Reviews. Clinical Oncology|June 15, 2016
Counselling framework for moderate-penetrance cancer-susceptibility mutationsNadine Tung, Susan M Domchek, Zsofia Stadler, et al.
Cancer Discovery|November 6, 2013
Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activityLijoy K Mathew, Samuel S Lee, Nicolas Skuli, et al.
Archives of Neurology|April 13, 1999
Successful use of alternate waste nitrogen agents and hemodialysis in a patient with hyperammonemic coma after heart-lung transplantationG T Berry, N D Bridges, K L Nathanson, et al.
Cancer Research|November 19, 2011
Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targetsVijay R Dondeti, Bradley Wubbenhorst, Priti Lal, et al.
Pageof 53